Kingworld Medicines Group (HKSE:01110) Total Stockholders Equity : HK$677 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group Total Stockholders Equity?

Kingworld Medicines Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$677 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Kingworld Medicines Group's Book Value per Share for the quarter that ended in Dec. 2023 was HK$1.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Kingworld Medicines Group's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.57.

Kingworld Medicines Group Total Stockholders Equity Historical Data

The historical data trend for Kingworld Medicines Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group Total Stockholders Equity Chart

Kingworld Medicines Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

671.37

701.54

755.37

687.42

677.09

Kingworld Medicines Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															755.37	750.00	687.42	732.18	677.09

Kingworld Medicines Group (HKSE:01110) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Kingworld Medicines Group's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(677.086	-	0)	/	622.5
	=	1.09

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Kingworld Medicines Group's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(216.6	+	171.064)	/	677.086
	=	0.57

Kingworld Medicines Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Kingworld Medicines Group (HKSE:01110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016

Website

https://www.kingworld.com.cn

Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines